Singulair

In the US, Singulair (montelukast systemic) is a member of the drug class leukotriene modifiers and is used to treat Asthma, Asthma - Maintenance, Bronchospasm Prophylaxis, COPD and Hay Fever.

US matches:

• Singulair


• Singulair Chewable Tablets


• Singulair Granules

UK matches:

• Singulair 10mg Tablets
• SINGULAIR PAEDIATRIC 4 mg GRANULES
• Singulair Paediatric 4 mg tablets
• Singulair Paediatric 5 mg Chewable Tablets
• Singulair 10 mg Tablets (SPC)
• SINGULAIR PAEDIATRIC 4 mg GRANULES (SPC)
• Singulair Paediatric 5 mg Chewable Tablets (SPC)

Ingredient matches for Singulair

Montelukast

Montelukast is reported as an ingredient of Singulair in the following countries:

• Tunisia

Montelukast sodium salt (a derivative of Montelukast) is reported as an ingredient of Singulair in the following countries:

• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Barbados


• Belgium


• Belize


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Canada


• Cayman Islands


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• El Salvador


• Estonia


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.